MDR-1
Showing 1 - 25 of >10,000
Hypertension Trial in Ankara (Genetic analysis and Losartan plazma level measurement)
Completed
- Hypertension
- Genetic analysis and Losartan plazma level measurement
-
Ankara, TurkeyGazi University
Apr 22, 2022
Tuberculosis, Multidrug Resistant Trial in Chernivtsi, Ivano-Frankivs'k, Kharkiv (RUTI® Therapeutic vaccine, Matching RUTI®
Terminated
- Tuberculosis, Multidrug Resistant
- RUTI® Therapeutic vaccine
- Matching RUTI® Placebo
-
Chernivtsi, Ukraine
- +2 more
Jun 30, 2022
Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Duarte (Brentuximab Vedotin, Cyclosporine, Pharmacokinetic
Active, not recruiting
- Recurrent Hodgkin Lymphoma
- Refractory Hodgkin Lymphoma
- Brentuximab Vedotin
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Tuberculosis, MDR Trial in Kazakhstan, Kyrgyzstan (FS-1, Placebo)
Completed
- Tuberculosis, MDR
- FS-1
- Placebo
-
Semey, East-Kazakhstan Region, Kazakhstan
- +5 more
May 17, 2022
Kidney Transplant Rejection Trial in Canada, United States (MDR-101)
Active, not recruiting
- Kidney Transplant Rejection
- MDR-101
-
La Jolla, California
- +19 more
Aug 22, 2022
Mild to Moderate Acne, Stiffness of Joint, Nec, Involving Ankle and Foot in MDR24_1, Other Specified Diseases of Hair and Hair
Active, not recruiting
- Mild to Moderate Acne
- +5 more
- Veg Collagen Peptide
- +3 more
-
Gandhi Nagar, Gujarat, IndiaNovoBliss Research Pvt Ltd
Jan 12, 2023
Household Transmission Dynamics of Multidrug Resistant
Not yet recruiting
- Adults Patients, With Fecal Carriage of Multi-Drug Resistant Enterobacterales (MDR-E)
- (no location specified)
Apr 3, 2023
Perinatal Transmission of MDR Bacteria
Recruiting
- E. Coli Infection
- Multi-antibiotic Resistance
-
Chicago, IllinoisPrentice Women's Hospital
Nov 20, 2023
Enterobacteriaceae Infections, Fecal Microbiota Transplantation Trial in France (Fecal Microbiota Transplantation (FMT)
Not yet recruiting
- Enterobacteriaceae Infections
- Fecal Microbiota Transplantation
- Fecal Microbiota Transplantation (FMT) capsules
- Placebo capsules
-
Clichy, France
- +10 more
Aug 2, 2022
Risk Factors for Multidrug Resistant Bacteria at ICU Admission
Not yet recruiting
- Multi Drug Resistant Bacteria
- Identification o Multi Drug Resistant Bacteria
- (no location specified)
Aug 2, 2023
Bone Resistant Tuberculosis
Completed
- Bone and Osteoarticular Infection Due to MDR M. Tuberculosis Strains
- Descriptive retrospective study
-
Paris, FrancePitié Salpêtrière Hospital
May 9, 2022
MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)
Active, not recruiting
- MDR-TB
- Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
- +9 more
-
Addis Ababa, Ethiopia
- +12 more
Oct 12, 2022
Ventilator Associated Pneumonia by Multi-Drug Resistant Organism
Completed
- Ventilator Associated Pneumonia
- Multi-antibiotic Resistance
- Ventilation
-
Muscat, OmanSultan Qaboos University Hospital
Sep 28, 2022
Factors Impacting the Prevalence of MDR Bacteria
Completed
- Multi-antibiotic Resistance
-
Najaf, IraqFaculty of pharmacy /kufa university
Aug 17, 2022
Tuberculosis, Multidrug-Resistant Trial in Dasmariñas, Hanoi (Delamanid, Levofloxacin, Bedaquiline)
Recruiting
- Tuberculosis, Multidrug-Resistant
- Delamanid
- +4 more
-
Dasmariñas, Philippines
- +1 more
Jun 21, 2022
Pulmonary Tuberculosis Trial (Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS), Pretomanid, Bedaquiline, OPC-167832, and
Not yet recruiting
- Pulmonary Tuberculosis
- Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS)
- +3 more
- (no location specified)
Jul 25, 2023
Multi-drug Resistant Tuberculosis Trial in China (18-month regimen containing 6 anti-TB drugs)
Completed
- Multi-drug Resistant Tuberculosis
- 18-month regimen containing 6 anti-TB drugs
-
Beijing, China
- +19 more
Oct 10, 2022
Tuberculosis, Pulmonary Trial in New Delhi, Tripura (RUTI®, Placebo)
Recruiting
- Tuberculosis, Pulmonary
- RUTI®
- Placebo
-
New Delhi, India
- +1 more
Mar 24, 2022
Kidney Transplant Rejection Trial (MDR-102, Immunosuppressive Agents)
Not yet recruiting
- Kidney Transplant Rejection
- MDR-102
- Immunosuppressive Agents
- (no location specified)
Apr 4, 2022
Breast Cancer Invasive Trial in Seoul (Leuplin or zoladex)
Recruiting
- Breast Cancer Invasive
- Leuplin or zoladex
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 16, 2022
AMR-DetecTool for the Diagnostic of MDR Bacterial Infections
Completed
- Bacterial Sensitivity Tests
- Antimicrobial Drug Resistance
- AMR LFIA Assay
-
Le Kremlin-Bicêtre, France
- +2 more
Jan 12, 2023
Tuberculosis, MDR Trial in Worldwide (Delamanid (DLM), Isoniazid (INH), Pyridoxine (vitamin B6))
Recruiting
- Tuberculosis, MDR
- Delamanid (DLM)
- +2 more
-
Gaborone, South-East District, Botswana
- +26 more
Sep 22, 2022
Acinetobacter Infections Trial in Bangkok (Colistin, Minocycline, Placebo)
Recruiting
- Acinetobacter Infections
- Colistin
- +2 more
-
Bangkok, ThailandFaculty of Medicine Siriraj Hospital, Mahidol University
Jan 13, 2023